Tonix Pharmaceuticals to Participate in the Stifel 2025 Healthcare Conference

Tonix Pharmaceuticals to Participate in the Stifel 2025 Healthcare Conference GlobeNewswire November 06, 2025 CHATHAM, N.J., Nov. 06, 2025 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully-integrated commercial biotechnology company, today announced that Seth Lederman, M.D., Tonix's Chief Executive Officer, will be presenting at the Stifel 2025 Healthcare […]

OTC Markets Group Welcomes SUN SILVER LTD. to OTCQX

OTC Markets Group Welcomes SUN SILVER LTD. to OTCQX GlobeNewswire November 06, 2025 NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced SUN SILVER LTD. (ASX: SS1; OTCQX: SSLVF), an Australian exploration company, has qualified to trade

Nokia Bell Labs and KDDI Research unite to drive innovation in 6G energy efficiency and network resiliency

(Helsinki:NOKIA),(Irish:IRSH),(LSE:0HAF),(Paris:NOKIA), Press ReleaseNokia Bell Labs and KDDI Research unite to drive innovation in 6G energy efficiency and network resiliency These two industry-leading research institutions are expanding their collaboration efforts to advance 6G technologies, setting the foundation for transformative connectivity solutions. The research collaboration will enable the commercialization of 6G networks that prioritize energy efficiency and

Sift positioned as a Leader in the SPARK Matrix(TM): eCommerce Fraud Prevention Solutions, 2025 by QKS Group

Sift positioned as a Leader in the SPARK Matrix(TM): eCommerce Fraud Prevention Solutions, 2025 by QKS Group GlobeNewswire November 06, 2025 Pune, India, Nov. 06, 2025 (GLOBE NEWSWIRE) — The QKS Group SPARK Matrix(TM) provides competitive analysis & ranking of the leading eCommerce Fraud Prevention Solution vendors. Sift, with its comprehensive eCommerce Fraud Prevention platform,

Microvast Schedules Third Quarter Earnings Call

Microvast Schedules Third Quarter Earnings Call GlobeNewswire November 06, 2025 STAFFORD, Texas, Nov. 06, 2025 (GLOBE NEWSWIRE) — Microvast Holdings, Inc. (NASDAQ: MVST), (“Microvast” or the “Company”), a global leader in advanced battery technologies, will issue a press release reporting its consolidated financial results for the third quarter of 2025 after market close on Monday,

MAX Power Strengthens Board to Support Next Phase of Growth

MAX Power Strengthens Board to Support Next Phase of Growth GlobeNewswire November 06, 2025 Saskatchewan Energy Leader Tom Kishchuk, Executive Director of the Global Institute for Energy, Minerals and Society, Joins MAX Power Board as Canada's First-Ever Natural Hydrogen Drill Program Gets Set To Begin MAX Power Saskatchewan Natural Hydrogen Documentary Videohttps://www.maxpowermining.com/NaturalHydrogen-NewEra/ SASKATOON, Saskatchewan, Nov.

Rapport Therapeutics Reports Third Quarter 2025 Financials and Provides Business Update

Rapport Therapeutics Reports Third Quarter 2025 Financials and Provides Business Update GlobeNewswire November 06, 2025 Positive topline results announced from Phase 2a clinical trial of RAP-219 in patients with focal onset seizures Phase 2 trial of RAP-219 in bipolar mania enrolling patients and on track, with topline results expected in the first half of 2027

Maze Therapeutics to Present Additional Data Highlighting the Advancement of MZE829 and MZE782 Programs at ASN Kidney Week

Maze Therapeutics to Present Additional Data Highlighting the Advancement of MZE829 and MZE782 Programs at ASN Kidney Week GlobeNewswire November 06, 2025 SOUTH SAN FRANCISCO, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) — Maze Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage biopharmaceutical company developing small molecule precision medicines for patients with kidney and metabolic diseases, today announced

Avenue Therapeutics Announces Acquisition of Subsidiary Baergic Bio by Axsome Therapeutics

Avenue Therapeutics Announces Acquisition of Subsidiary Baergic Bio by Axsome Therapeutics Baergic shareholders eligible to receive up to approximately $82 million in potential development, regulatory, and sales milestones plus a tiered mid-to-high single digit royalty on global net sales from Axsome GlobeNewswire November 06, 2025 MIAMI, Nov. 06, 2025 (GLOBE NEWSWIRE) — Avenue Therapeutics, Inc.

Commerce Announces Third Quarter 2025 Financial Results

Commerce Announces Third Quarter 2025 Financial Results Third Quarter Total Revenue of $86.0 Million, an Increase of 3% Versus Prior Year. Total ARR of $355.7 Million, an Increase of 2% Versus Prior Year. Enterprise ARR of $269.2 Million, an Increase of 5% Versus Prior Year GlobeNewswire November 06, 2025 AUSTIN, Texas, Nov. 06, 2025 (GLOBE

Scroll to Top